Pregnancy and pharmacology

  • 4,629 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
4,629
On Slideshare
0
From Embeds
0
Number of Embeds
2

Actions

Shares
Downloads
203
Comments
0
Likes
4

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. UNIT 4:PHARMACOLOGY AND PREGNANCY
  • 2. DRUG THERAPY IN PREGNANCY During pregnancy most drugs can cross the placenta and expose the baby to their effects Factors affecting placental drug transfer and drug effects on the fetus include  Drug physiochemical properties  Rate at which drug crosses placenta and amount reaching the fetus  Duration of drug exposure  Distribution in different fetal tissues  Stage of placental and fetal development  Effects of drugs used in combination
  • 3. PREGNANCY INDUCED MATERNAL PHYSIOLOGIC CHANGES Gastrointestinal absorption  Decreased GI motility  Secondary to progesterone levels  Reduction in gastric acid secretion  Increase in gastric mucus secretion  Increase in gastric pH, therefore negatively affects drugs that require acidic pH for absorption  Nausea and vomiting Lung absorption  Cardiac and tidal volumes increase by approximately by 50% in pregnancy.  Hyperventilation and increased pulmonary blood flow Transdermal absorption  Increase in peripheral vasodilation and increase in blood flow to the skin.  Enhanced transdermal absorption
  • 4. PHYSIOLOGIC CHANGES IN PREGNANCYOrgan System Dynamic Change during pregnancy CardiovascularBlood volume Increased by 30-50%Cardiac output Increased by 30-50%Systemic vascular resistance DecreasedOrgan System Dynamic Change during pregnancy GastrointestinalpH of intestinal secretions IncreasedGastric emptying time IncreasedGastric acid secretions DecreasedIntestinal motility Decreased
  • 5. PHYSIOLOGIC CHANGES IN PREGNANCYOrgan System Dynamic Change During Pregnancy KidneyRenal Blood Flow rate IncreasedGlomerular Filtration rate IncreasedOrgan System Dynamic Change during Pregnancy GynecologicUterine Blood Flow Increased
  • 6. LIPID SOLUBILITY Drug passage through the placenta is depended on lipid solubility and degree of ionization  Example: Salicylate Lipophilic drugs tend to diffuse readily across the placenta and enter the fetal circulation  Example: Thiopental use during cesarean sections may cause apnea in the newborn Impermeability to polar compounds is relative rather an absolute  Achieved during high enough maternal-fetal concentration gradient
  • 7. MOLECULAR WEIGHT (MW) Influences the rate and amount of drug transferred across the placenta Depending on lipid solubility and degree of ionization the following rule for MW apply  250-500: Cross the placenta easily  500-1000: Cross with more difficulty  > 1000: cross very poorly Clinical application  Heparin is large and polar, thus unable to cross the placenta  Provides alternative to coumadin, which is teratogenic
  • 8. PLACENTAL TRANSPORTERS Several drug transporters have been identified in the placenta There is increasing recognition of their effects on drug transfer to the fetus P-glycoprotein transporter  Pumps back into maternal circulation a variety of drugs and other agents  Example: cancer drugs and viral protease inhibitors Clinical benefit  Prevention of toxic effects to the fetus
  • 9. PHARMACODYNAMIC FACTORS INFLUENCING DRUG THERAPY Maternal drug actions  Physiology of some organs (heart, lungs, kidneys, CNS) may be altered by pregnancy  May require the use of drugs not needed by the same woman when she is not pregnant  Example: Diuretics in pregnancy induced HF Fetal therapeutics  Involves drug administration to the pregnant woman with the fetus as the drug target  Example: Corticosteroids to stimulate lung maturation when pre -term birth is expected
  • 10. PHARMACODYNAMIC FACTORS INFLUENCING DRUG THERAPY Predictable toxic drug actions in the fetus  Neonatal withdrawal syndrome  Caused by chronic use of opioids by the mother  Use of teratogenic drugs during pregnancy  ACEI causing renal damage to the fetus Teratogenic mechanisms (multifactorial)  Direct drug effects on maternal tissues with indirect effects on fetal tissue  Direct effects on processes for tissue differentiation  Deficiency in a critical substance  folic acid prevents spina bifida
  • 11. PHARMACODYNAMIC FACTORS INFLUENCING DRUG THERAPY To be considered teratogenic a substance should  Result in a characteristic set of malformations  Exert its effects at a particular stage of fetal development  Show a dose dependent incidence FDA teratogenic risk categories  Attempt to quantify teratogenic risk  Range from A (safe) to X (definite human teratogenic risk)
  • 12. SELECTED DRUGS WITH SIGNIFICANT ADVERSE EFFECTS ON THE FETUS Drug Trimester EffectACEI All, Renal damageTCAs Third Neonatal withdrawal syndromeBarbiturates All Chronic use: Neonatal dependenceCarbamazepine First Neural tube defectsCocaine, tamoxifen All Risk of spontaneous abortionEthanol All Fetal alcohol syndromeIodine All Congenital goiter, hypothyroidismLithium First Icreased ICPTobacco All Intrauterine growth retardationTetracycline All Discoloration of teeth and altered bone growthThalidomide & DES First Limb malformation (DES Cancer Risk Icreased)Warfarin First Alters respiratory tract formation Second CNS malformation Third Risk of bleeding – IC hemorrhage
  • 13. DRUG ABSORPTION Absorption after IM or SC injections in neonates depends on  Blood flow to the area and gastrointestinal function Blood flow is reduced by  Cardiovascular shock, vasoconstriction, HF, very little muscle mass and diminished perfusion of area GI function in the neonate changes significantly after birth  Full-term: GI secretions begin soon after birth  Pre-term: GI secretions begin more slowly  Gastric emptying time is by 6-8hrs  Peristalsis is irregular and may be slow  Gastrointestinal enzymes tend to be lower
  • 14. DRUG USE DURING PREGNANCY AND LACTATION Most drugs given to lactating women are detectable in breast milk Concentrations are usually low, preventing infants form receiving therapeutic amounts Some drugs carry serious toxicities and must be avoided  Example: Radioactive iodine, cancer chemotherapy Recommendations for feeding mothers  Safe drug: Take it 30-60 minutes after nursing and 3-4 hours before the next feeding  No safety data: Avoid drug use or discontinue breast feeding
  • 15. POSSIBLE EFFECTS ON INFANT OF SELECTED DRUGS USED DURING LACTATION Drug CommentsTetracycline Risk of permanent tooth staining in infantIsoniazid Risk of pyridoxine deficiency in the infantBarbiturates Lethargy, sedation and poor suck reflexesChloral hydrate Drowsiness if infant fed at peakDiazepam Drug accumulation and sedationMethadone Risk of withdrawal if breast feeding stopsIodine Thyroid suppression and risk of cancerPropylthiouracil Can suppress thyroid function in infant